Literature DB >> 24404588

Oxidatively modified LDL particles in the human placenta in early and late onset intrauterine growth restriction.

U Pecks, W Rath, R Caspers, K Sosnowsky, B Ziems, H-J Thiesen, N Maass, B Huppertz.   

Abstract

INTRODUCTION: Reduced serum LDL concentrations have been observed in pregnancies complicated by intrauterine growth restriction (IUGR) as compared to healthy pregnant women. Since increased oxidative stress has been suggested to play a major role in IUGR we now hypothesized that the lower LDL concentrations are accompanied by an accumulation of oxidized LDLs in the placenta.
METHODS: Fifteen placentas of near term and preterm born IUGR, and a gestational age matched control group (CTRL n = 15) were analyzed. Placental minimal modified LDL and fully oxidized LDL particles were measured by ELISA, and by immunohistochemistry, and were related to maternal and fetal serum lipid profiles.
RESULTS: We found fully oxidized LDL but not minimal modified LDL being increased in the preterm subgroup of IUGR (n = 10) as compared to preterm CTRL (n = 10; p < 0.05). An increased staining intensity of trophoblasts in preterm IUGR subjects as compared to preterm CTRL has been confirmed by immunohistochemistry (p < 0.05). No difference could be found between the term groups (n = 5 each). Correlation analysis revealed an inverse relationship of maternal LDL (ρ = −0.49, p = 0.03) and fetal HDL cholesterol (ρ = −0.46, p = 0.04) with placental fully oxidized LDL particle concentration within preterms. DISCUSSION: IUGR is a heterogeneous entity. Different pathomechanisms seem to underlie the disease in preterm and term subjects with oxidation of LDL within the placenta possibly taking place in preterm IUGRs.
CONCLUSIONS: We conclude that the reduced maternal LDL cholesterol concentration in IUGR pregnancies is attributed to increased accumulation of oxidized LDL particles within the placenta at least in early onset IUGR

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24404588     DOI: 10.1016/j.placenta.2013.10.006

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  9 in total

1.  Maternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic Pathologies.

Authors:  U Pecks; W Rath; N Kleine-Eggebrecht; N Maass; F Voigt; T W Goecke; M G Mohaupt; G Escher
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-07       Impact factor: 2.915

2.  Increased maternal and fetal cholesterol efflux capacity and placental CYP27A1 expression in preeclampsia.

Authors:  Hiten D Mistry; Lesia O Kurlak; Yosef T Mansour; Line Zurkinden; Markus G Mohaupt; Geneviève Escher
Journal:  J Lipid Res       Date:  2017-04-10       Impact factor: 5.922

3.  Early onset intrauterine growth restriction in a mouse model of gestational hypercholesterolemia and atherosclerosis.

Authors:  Dolores Busso; Lilian Mascareño; Francisca Salas; Loni Berkowitz; Nicolás Santander; Alonso Quiroz; Ludwig Amigo; Gloria Valdés; Attilio Rigotti
Journal:  Biomed Res Int       Date:  2014-09-10       Impact factor: 3.411

4.  Fetal gender and gestational age differentially affect PCSK9 levels in intrauterine growth restriction.

Authors:  Ulrich Pecks; Werner Rath; Nicolai Maass; Bartlomiej Berger; Imke Lueg; André Farrokh; Sabrina Farrokh; Christel Eckmann-Scholz
Journal:  Lipids Health Dis       Date:  2016-11-14       Impact factor: 3.876

5.  Maternal lipids and leptin concentrations are associated with large-for-gestational-age births: a prospective cohort study.

Authors:  Dayana Rodrigues Farias; Lucilla Poston; Ana Beatriz Franco-Sena; Antônio Augusto Moura da Silva; Thatiana Pinto; Lívia Costa de Oliveira; Gilberto Kac
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

6.  Effects of modified lipoproteins on human trophoblast cells: a role in pre-eclampsia in pregnancies complicated by diabetes.

Authors:  Rebecca Helen McLeese; Jiawu Zhao; Dongxu Fu; Jeremy Y Yu; Derek P Brazil; Timothy J Lyons
Journal:  BMJ Open Diabetes Res Care       Date:  2021-01

7.  Maternal lipid profile in pregnancy and embryonic size: a population-based prospective cohort study.

Authors:  Dionne V Gootjes; Anke G Posthumus; Deveney F Wols; Yolanda B de Rijke; Jeanine E Roeters Van Lennep; Eric A P Steegers
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-18       Impact factor: 3.105

8.  The association between maternal lipid profile after birth and offspring risk of autism spectrum disorder.

Authors:  Bo Y Park; Ruofan Yao; Elaine Tierney; Martha Brucato; Xiumei Hong; Guoying Wang; Yuelong Ji; Colleen Pearson; M Daniele Fallin; Xiaobin Wang; Heather Volk
Journal:  Ann Epidemiol       Date:  2020-09-09       Impact factor: 3.797

9.  Estimating fetal cholesterol synthesis rates by cord blood analysis in intrauterine growth restriction and normally grown fetuses.

Authors:  Ulrich Pecks; Verena Bornemann; Anika Klein; Laura Segger; Nicolai Maass; Ibrahim Alkatout; Christel Eckmann-Scholz; Mohamed Elessawy; Dieter Lütjohann
Journal:  Lipids Health Dis       Date:  2019-10-25       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.